吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jul 22 2022

Full Issue

Monkeypox Research Gets $140M Boost From White House

The money is aimed at a 22-target research agenda, hopefully to understand and control rising cases. Meanwhile, the House Oversight and Reform Committee told the Department of Health and Human Services to address barriers that some people have found in accessing monkeypox treatments.

The White House announced Thursday a $140 million, 22-target research agenda for monkeypox to better understand and handle rising case counts across the country. The agenda aims to improve data on transmission, testing, vaccines, equitable treatments and environmental factors. (Payne, 7/21)

Rep. Carolyn Maloney (D-N.Y.), chair of the House Oversight and Reform Committee, on Wednesday asked the Department of Health and Human Services (HHS) to address the 鈥渂arriers鈥 to monkeypox treatment that people have reported dealing with so far. (Choi, 7/21)

Monkeypox patients around the world are suffering from symptoms not normally linked to the virus, leading to missed and mistaken diagnoses, researchers said. (Muller, 7/21)

The spread of monkeypox in the U.S. could represent the dawn of a new sexually transmitted disease, though some health officials say the virus that causes pimple-like bumps might yet be contained before it gets firmly established. Experts don鈥檛 agree on the likely path of the disease, with some fearing that it is becoming so widespread that it is on the verge of becoming an entrenched STD 鈥 like gonorrhea, herpes and HIV. (Stobbe, 7/22)

Vaccines for the monkeypox virus should be prioritized for men who have sex with men, according to experts. (Thomson, 7/21)

The WHO is considering the global monkeypox risk 鈥

During opening remarks, WHO Director-General Tedros Adhanom Ghebreyesus, PhD, said worldwide cases are mostly still in men who have sex with men (MSM). (Soucheray, 7/21)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 4
  • Monday, August 3
  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF